INSURANCE/HEALTH: Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (RE NO IMPACT See Note)

Sponsors & Cosponsors

Roll Call Votes

Actions Timeline

1. Read second time by title and referred to the Committee on Insurance.

   4/15/2026Senate

2. Received in the Senate. Read first time by title and placed on the Calendar for a second reading.

   4/14/2026Senate

3. Called from the calendar.

   4/13/2026House

4. Read third time by title, amended, roll called on final passage, yeas 96, nays 0. Finally passed, title adopted, ordered to the Senate.

   4/13/2026House

5. Read by title, returned to the calendar.

   4/9/2026House

6. Notice given.

   4/9/2026House

7. Scheduled for floor debate on 04/13/2026.

   4/9/2026House

8. Scheduled for floor debate on 04/09/2026.

   4/8/2026House

9. Read by title, amended, ordered engrossed, passed to 3rd reading.

   4/7/2026House

10. Reported with amendments (10-0).

    4/1/2026House

11. Read by title, under the rules, referred to the Committee on Insurance.

    3/9/2026House

12. Prefiled.

    2/27/2026House

13. Under the rules, provisionally referred to the Committee on Insurance.

    2/27/2026House

14. First appeared in the Interim Calendar on 2/27/2026.

    2/27/2026House

Bill Text

• Engrossed

  PDF

• Introduced

  PDF

• Reengrossed

  PDF